FEDERAL HEALTH AGENCY STREAMLINES DRUG APPROVALS IN RESPONSE TO COVID-19 CRISIS
Highly skilled employees at a major health-related government regulatory, research and testing agency are spending a lot of time on manual, repetitive, and administrative tasks. In the COVID-19 crisis, the time and expertise of health experts must be devoted to driving drug approvals without impacting quality.
Processes such as drug intake forms, administrative tasks, mining insight, resource allocation, and risk assessment were automated. For high-volume activities, bots now run the first wave of analytics on applications. The agency was able to reallocate workers to higher-value tasks, saving a total of 24,000 hours per year with automation.
Technical experts to mission activities
24,000 hours of manual, repetitive, administrative work